C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, Including Darunavir

Journal of Virology - United States
doi 10.1128/jvi.01829-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Novel Protease Inhibitors Containing C-5-Modified Bis-THF and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity Against Highly Multidrug-Resistant HIV-1 With High Genetic Barrier Against the Emergence of Drug Resistance.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Investigating PIs

Nature Chemical Biology
Cell BiologyMolecular Biology
2020English

Assessment of in Vitro Bioactivities of Pis v 1 (2S Albumin) and Pis v 2.0101 (11S Globulin) Proteins Derived From Pistachio (Pistacia Vera L.)

Journal of Food Measurement and Characterization
IndustrialRiskFood ScienceManufacturing EngineeringReliabilitySafetyChemical EngineeringQuality
2019English

HIV-1 Protease Inhibitors From Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2008English

PIS Forn-Coupled Nonlinear Systems

International Journal of Mathematics and Mathematical Sciences
Mathematics
1980English

STKE: PIs as Ligands?

Science
MultidisciplinaryPhilosophy of ScienceHistory
2005English

Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

Amino Acid Insertions Near Gag Cleavage Sites Restore the Otherwise Compromised Replication of Human Immunodeficiency Virus Type 1 Variants Resistant to Protease Inhibitors

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI)(GRL-001-15 and GRL-003-15) With the Flap of Protease Are Critical for Their Potent Activity Against Wild-Type and Multi-Pi-Resistant HIV-1 Variants

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy